Tag

The panel will discuss ESG shareholder activism and corporate business strategies, programs and policies, as related to raising capital, M&A and profitability, board and C-level engagement, internal control, disclosure and corporate governance required to address known and...

M&A activity is still significantly above pre-pandemic levels, with healthcare remaining one of the most active industries transactionally. The panel will discuss M&A trends by healthcare verticals, labor and supply chain shortages, financing availability, valuations and...

The panel will discuss structural and disclosure, regulatory and accounting considerations, as well as internal controls and corporate governance issues arising in SPAC transactions as well as potential conflicts and litigation risks, including SEC scrutiny and private lawsuits.